Publications for Ulf Stenestrand
Co-author map based on ISI articles 2007-

Publications mentioned in social media 27 times*

Keywords

women treatment stents stemi risk renal registry register pci patients myocardial mi intensive infarction heart disease discharge death coronary (95%

Journal Articles

Sara Aspberg, Ulf Stenestrand, Max Koster and Thomas Kahan
  Large differences between patients with acute myocardial infarction included in two Swedish health registers
  Scandinavian Journal of Public Health, 2013, 41(6), 637-643.
 Web of Science® Times Cited: 1

Imre Janszky, Staffan Ahnve, Kenneth J Mukamal, Shiva Gautam, Lars Wallentin and Ulf Stenestrand
  Daylight saving time shifts and incidence of acute myocardial infarction - Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
 
Altmetric usage: 24

  Sleep Medicine, 2012, 13(3), 237-242.
 Web of Science® Times Cited: 9

Thao Huynh, John Birkhead, Kurt Huber, Jennifer OLoughlin, Ulf Stenestrand, Clive Weston, Tomas Jernberg, Michael Schull, Robert C Welsh, Ali E Denktas, Andrew Travers, Sunil Sookram, Pierre Theroux, Jack V Tu, Adams Timmis, Richard Smalling and Nicolas Danchin
  The Pre-Hospital Fibrinolysis Experience in Europe and North America and Implications for Wider Dissemination
  JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4(8), 877-883.
 Web of Science® Times Cited: 5

Jonas Persson, Johan Lindback, Claes Hofman-Bang, Bo Lagerqvist, Ulf Stenestrand and Ann Samnegard
  Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome
  EUROINTERVENTION, 2011, 6(9), 1046-1052.
 Web of Science® Times Cited: 3

Karolina Szummer, Pia Lundman, Stefan H Jacobson, Staffan Schon, Johan Lindback, Ulf Stenestrand, Lars Wallentin and Tomas Jernberg
  Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction
  KIDNEY INTERNATIONAL, 2011, 79(9), 997-1004.
 Web of Science® Times Cited: 12

Johan Höglund, Ulf Stenestrand, Tim Tödt and Ingela Johansson
  The effect of early mobilisation for patient undergoing coronary angiography; A pilot study with focus on vascular complications and back pain
  European Journal of Cardiovascular Nursing, 2011, 10(2), 130-136.
 Web of Science® Times Cited: 4

Jonas F Ludvigsson, Stefan James, Johan Askling, Ulf Stenestrand and Erik Ingelsson
  Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease
  CIRCULATION, 2011, 123(5), 483-U239.
 Web of Science® Times Cited: 15

Sofia Lawesson, Tim Tödt, Joakim Alfredsson, Magnus Janzon, Ulf Stenestrand and Eva Swahn
  Gender difference in prevalence and prognostic impact of renal insufficiency in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
  Heart, 2011, 97(4), 308-314.
   Fulltext  PDF  
 Web of Science® Times Cited: 10

H Hemingway, Martin Henriksson, R. Chen, J. Damant, N. Fitzpatrick, K. Abrams, A. Hingorani, Magnus Janzon, M. Shipley, G. Feder, B. Keogh, Ulf Stenestrand, K. McAllister, J-C Kaski, A. Timmis, S. Palmer and M. Sculpher
  The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.
  Health Technology Assessment, 2010, 14(9), .
 Web of Science® Times Cited: 8

Tomas Jernberg, Mona F Attebring, Kristina Hambraeus, Torbjorn Ivert, Stefan James, Anders Jeppsson, Bo Lagerqvist, Bertil Lindahl, Ulf Stenestrand and Lars Wallentin
  The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
  Heart, 2010, 96(20), 1617-1621.
 Web of Science® Times Cited: 51

Jonas Oldgren, Lisa Wernroth and Ulf Stenestrand
  Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA
  HEART, 2010, 96(18), 1451-1457.
 Web of Science® Times Cited: 7

Ulf Stenestrand, Magnus Wijkman, Mats Fredrikson and Fredrik H Nystrom
  Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain.
  Journal of the American Medical Association (JAMA), 2010, 303(12), 1167-1172.
 Web of Science® Times Cited: 6

Tim Tödt, Sofia Sederholm-Lawesson, Ulf Stenestrand, Joakim Alfredsson, Magnus Janzon and Eva Swahn
  Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery
  Acute cardiac care, 2010, 12(1), 10-17.

Lena Bjorck, Lars Wallentin, Ulf Stenestrand, George Lappas and Annika Rosengren
  Medication in Relation to ST-Segment Elevation Myocardial Infarction in Patients With a First Myocardial Infarction Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
  ARCHIVES OF INTERNAL MEDICINE, 2010, 170(15), 1375-1381.
 Web of Science® Times Cited: 9

Axel Akerblom, Stefan K James, Michail Koutouzis, Bo Lagerqvist, Ulf Stenestrand and Bodil Svennblad
  Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)
 
Altmetric usage: 1

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56(6), 470-475.
 Web of Science® Times Cited: 27

K. Szummer, P. Lundman, S.H. Jacobson, S. Schon, J. Lindback, Ulf Stenestrand, L. Wallentin and T. Jernberg
  Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register
  Journal of Internal Medicine, 2010, 268(1), 40-49.
 Web of Science® Times Cited: 20

Karolina Szummer, Pia Lundman, Stefan H. Jacobson, Johan Lindback, Ulf Stenestrand, Lars Wallentin and Tomas Jernberg
  Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: Data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
  American Heart Journal, 2010, 159(6), 979-986.
 Web of Science® Times Cited: 14

Christos Milonas, Tomas Jernberg, Johan Lindback, Stefan Agewall, Lars Wallentin and Ulf Stenestrand
  Effect of Angiotensin-Converting Enzyme Inhibition on One-Year Mortality and Frequency of Repeat Acute Myocardial Infarction in Patients With Acute Myocardial Infarction
  AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105(9), 1229-1234.
 Web of Science® Times Cited: 12

Klas Gransbo, Johan Lindback, Ulf Stenestrand, Jorg Carlsson and Jan Nilsson
  Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
 
Altmetric usage: 1

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55(13), 1362-1369.
 Web of Science® Times Cited: 19

Sofia Lawesson, Ulf Stenestrand, Bo Lagerqvist, Lars Wallentin and Eva Swahn
  Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction
  Heart, 2010, 96(6), 453-459.
 Web of Science® Times Cited: 16

Martin Henriksson, Jacqueline Damant, Natalie K Fitzpatrick, Keith Abrams, Aroon D Hingorani, Ulf Stenestrand, Magnus Janzon, Gene Feder, Bruce Keogh, Martin J Shipley, Juan-Carlos Kaski, Adam Timmis, Mark Sculpher and Harry Hemingway
  Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery
  BRITISH MEDICAL JOURNAL, 2010, 340, .
 Web of Science® Times Cited: 19

Ulf Stenestrand, Stefan K James, Johan Lindback, Ole Frobert, Jorg Carlsson, Fredrik Schersten, Tage Nilsson and Bo Lagerqvist
  Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
  EUROPEAN HEART JOURNAL, 2010, 31(2), 177-186.
 Web of Science® Times Cited: 20

Bo Lagerqvist, Jörg Carlsson, Ole Fröbert, Johan Lindbäck, Fredrik Scherstén, Ulf Stenestrand and Stefan K James
  Stent thrombosis in sweden: a report from the Swedish coronary angiography and angioplasty registry.
  CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2(5), 401-408.
 Web of Science® Times Cited: 39

Joakim Alfredsson, Sofia Sederholm-Lawesson, Ulf Stenestrand and Eva Swahn
  Although women are less likely to be admitted to coronary care units, they are treated equally to men and have better outcome: A prospective cohort study in patients with non ST-elevation acute coronary syndromes
  Acute cardiac care, 2009, 11(3), 173-180.

Ulf Stenestrand
  Fler patienter med stabil angina bör behandlas med PCI
  Läkartidningen, 2009, 106(36), 2204-2205.

J Knot, P Widimsky, W Wijns, Ulf Stenestrand, SD Kristensen, A Van´T Hof, F Weidinger, Magnus Janzon, BL Nörgaard, JT Soerensen, van de Wetering, K Thygesen, PA Bergsten, C Digerfeldt, A Potgieter, N Tomer and Fajadet
  How to set up an effective national primary angioplasty network: Lessons learned from five European countries
  EuroIntervention, 2009, 3(299), 301-309.
 Web of Science® Times Cited: 21

L. Bjorck, A. Rosengren, L. Wallentin and Ulf Stenestrand
  Smoking in relation to ST-segment elevation acute myocardial infarction: Findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions
  Heart, 2009, 95(12), 1006-1011.
 Web of Science® Times Cited: 14

S.K. James, Ulf Stenestrand, J. Lindback, J. Carlsson, F. Schersten, T. Nilsson, L. Wallentin and B. Lagerqvist
  Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
 
Altmetric usage: 1

  New England Journal of Medicine, 2009, 360(19), 1933-1945.
 Web of Science® Times Cited: 114

Karolina Szummer, Pia Lundman, Stefan H Jacobson, Staffan Schoen, Johan Lindbaeck, Ulf Stenestrand, Lars Wallentin and Tomas Jernberg
  Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)
  CIRCULATION, 2009, 120(10), 851-U55.
 Web of Science® Times Cited: 49

Ole Frobert, Bo Lagerqvist, Jorg Carlsson, Johan Lindback, Ulf Stenestrand and Stefan K James
  Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus A Report From the SCAAR (Swedish Angiography and Angioplasty Registry)
  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53(18), 1660-1667.
 Web of Science® Times Cited: 53

Jorg Carlsson, Stefan K James, Johan Lindback, Fredrik Schersten, Tage Nilsson, Ulf Stenestrand and Bo Lagerqvist
  Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria
  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53(16), 1389-1398.
 Web of Science® Times Cited: 24

A Norhammar, Ulf Stenestrand, J Lindback and L Wallentin
  Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA)
  Heart, 2008, 94(12), 1565-1570.
 Web of Science® Times Cited: 23

Bo Lagerqvist, Stefan K. James, Ulf Stenestrand, Johan Lindbäck, Tage Nilsson and Lars Wallentin
  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
  New England Journal of Medicine, 2007, 356(10), 1009-1019.
 Web of Science® Times Cited: 684

Joakim Alfredsson, Ulf Stenestrand, Lars Wallentin and Eva Swahn
  Gender differences in management and outcome in non-ST-elevation acute coronary syndrome
  Heart, 2007, 93(11), 1357-1362.
 Web of Science® Times Cited: 56

F Tabrizi, A Englund, M Rosenqvist, L Wallentin and Ulf Stenestrand
  Influence of left bundle branch block on long-term mortality in a population with heart failure
  European Heart Journal, 2007, 28(20), 2449-2455.
 Web of Science® Times Cited: 20

A Norhammar, J Lindbäck, L Rydén, L Wallentin and Ulf Stenestrand
  Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: A time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission
  Heart, 2007, 93(12), 1577-1583.
 Web of Science® Times Cited: 58

C Held, P Tornvall and Ulf Stenestrand
  Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery
  European Heart Journal, 2007, 28(3), 316-325.
 Web of Science® Times Cited: 6

Ulf Stenestrand, Johan Lindbäck and Lars Wallentin
  Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction - Reply
  Journal of the American Medical Association (JAMA), 2007, 297(12), 1314-1315.

Ulf Stenestrand, B Lindahl and L Wallentin
  Hjärtinfarktvården kraftigt förbättrad 1995 - 2005 med stöd av kvalitetsregister, öppna redovisningar och tydliga behandlingsmål
  Läkartidningen, 2007, 104, 1580-1583.

P Hallberg, J Lindbäck, B Lindahl and Ulf Stenestrand
  Digoxin and mortality in atrial fibrillation: A prospective cohort study
 
Altmetric usage: 0

  European Journal of Clinical Pharmacology, 2007, 63(10), 959-971.
 Web of Science® Times Cited: 22

T Nilsson, H Olsson, J Lugnegård and Ulf Stenestrand
  PCI-etablering i Värmland har gett resultat: 30-Dagarsdödligheten i hjärtinfarkt har halverats
  Läkartidningen, 2007, 104(44), 3284-3286.

Ulf Stenestrand, Bertil Lindahl and Lars Wallentin
  Vad som behövs är mer kunskaper - inte diffus "läkekonst"
  Läkartidningen, 2007, 104(32-33), 2259-2262.

Ulf Stenestrand
  Sena stenttromboser ett negligerat problem? Indikationer tyder på ökad risk med läkemedelsstent
  Läkartidningen, 2006, 103(39), 2838-2839.

Ulf Stenestrand and Lars Wallentin
  Primary PCI: Better in the real world, too.
  Audio Journal of Cardiovascular Medicine, 2006, 12, .

Ulf Stenestrand
  Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents.
  Läkartidningen, 2006, 103, 2838-2839.

Ulf Stenestrand
  CRP ingen riskmarkör för normalbefolkningen.
  Läkartidningen, 2006, 103, 3801-3801.

Ulf Stenestrand, Johan Lindbäck and Lars Wallentin
  Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction
  Journal of the American Medical Association (JAMA), 2006, 296(14), 1749-1756.
 Web of Science® Times Cited: 149

Erik Björklund, Ulf Stenestrand, Johan Lindbäck, Leif Svensson and Bertil Lindahl
  Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction
  European Heart Journal, 2006, 27(10), 1146-1152.
 Web of Science® Times Cited: 60

Ulf Stenestrand
  Sena stentromboser vid läkemedelsstent ett negligerat problem.
  Läkartidningen, 2006, 103, 2839-2840.

E Björklund, Ulf Stenestrand, J Lindbäck, L Svensson, L Wallentin and B Lindahl
  Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI
  Journal of Electrocardiology, 2005, 38, 186-186.

Ulf Stenestrand
  Improper statistics explanation for surprising outcome in the GRACE-study of access to catheterisation facilities in patients admitted with ACS
  British Medical Journal, 2005, 330, 441-441.

Ulf Stenestrand
  Tid är hjärtmuskel. Snabbare handläggning och reperfusion räddar fler med ST-höjningsinfarkt
  Läkartidningen, 2005, 102, 3008-3008.

Peter Lindgren, Ulf Stenestrand, Klas Malmberg and Bengt Jönsson
  The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
  Clinical Therapeutics, 2005, 27(1), 100-110.
 Web of Science® Times Cited: 12

Ulf Stenestrand, Johan Lindbäck and Lars Wallentin
  Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: A prospective cohort study from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)
  Circulation, 2005, 112(21), 3225-3231.
 Web of Science® Times Cited: 47

Ulf Stenestrand, Johan Lindbäck and Lars Wallentin
  Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction
  American Heart Journal, 2005, 149(1), 82-90.
 Web of Science® Times Cited: 14

Ulf Stenestrand
  Högsensitivt CRP indikerar risk för att utveckla hypertoni
  Läkartidningen, 2004, 20, 1788-1788.

Ulf Stenestrand
  Bättre resultat med ballongvidgning än med fibrinolys vid akut hjörtinfarkt
  Läkartidningen, 2004, 3, 176-176.

Ulf Stenestrand, F Tabrizi, J Lindbäck, A Englund, M Rosenqvist and L Wallentin
  Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block
  Circulation, 2004, 110(14), 1896-1902.
 Web of Science® Times Cited: 39

E Bjorklund, B Lindahl, Ulf Stenestrand, Eva Swahn, M Dellborg, K Pehrsson, F Van De Werf and L Wallentin
  Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial
  American Heart Journal, 2004, 148(4), 566-573.
 Web of Science® Times Cited: 35

Ulf Stenestrand and Anders Olsson
  Ju lägre LDL-kolesterol destö bättre!
  Läkartidningen, 2004, 101, 3246-3247.

Ulf Stenestrand and Lars Wallentin
  Fibrinolytic therapy in patients 75 years and older with ST-wegment–elevation myocardial infarction: one-year follow-up of a large prospective cohort
  Archives of Internal Medicine, 2003, 163(8), 965-971.
 Web of Science® Times Cited: 46

Ulf Stenestrand
  Dagens HIA-vård i Sverige
  Incitament, 2003, 1, 682-685.

Ulf Stenestrand
  Kvalitetsregister minska nationella skillnader in hjärtinfarktvården.
  Läkartidningen, 2003, 99, 830-830.

Anna Norhammar, Klas Malmberg, Lars Rydén, Per Tornvall, Ulf Stenestrand and Lars Wallentin
  Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction
  European Heart Journal, 2003, 24(9), 838-844.
 Web of Science® Times Cited: 78

Ulf Stenestrand and L Wallentin
  Early revascularisation for myocardial infarction
  The Lancet, 2002, 360, 1603-1603.

Ulf Stenestrand and Lars Wallentin
  Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study
  The Lancet, 2002, 359(9320), 1805-1811.
 Web of Science® Times Cited: 78

Ulf Stenestrand
  Ny studie på högsensitivt CRP ger råd om statinbehandling för primärprevention av kardiovaskulär sjukdom
  Läkartidningen, 2001, 98, .

Ulf Stenestrand and Lars Wallentin
  Early statin treatment following acute myocardial infarction and 1-year survival
  Journal of the American Medical Association (JAMA), 2001, 285(4), 430-436.
 Web of Science® Times Cited: 337

Chapters in Books

Ulf Stenestrand
  Sjukdomsbild, vård och modern vårdprocess vid akut kranskärlssjukdom
  Akut kranskärlssjukdom, Liber AB, 2005, -304.


L Wallentin and Ulf Stenestrand
  Förekomst och utveckling av kranskärlssjukvård i Sverige
  Akut kranskärlssjukdom, Liber AB, 2005, -304.


Ulf Stenestrand
  Dagens sjukvård vid akut kranskärlssjukdom
  Akut kranskärlssjukdom, Linköpings universitet, 2002, 183-188.


Conference Articles

M Koutouzis, A Rosengren, L Bjork, P Albertsson, L Grip, G Matejka, Ulf Stenestrand and P Johanson
  Acute coronary syndromes in nonagenarians in Sweden. A report from the register of Information and Knowledge about Swedish Seart Intensive care Admissions (RIKS-HIA) in EUROPEAN HEART JOURNAL, vol 31, issue , pp 308-308
  EUROPEAN HEART JOURNAL, 2010.


Fredrik Nyström, Magnus Wijkman, M. Fredriksson and Ulf Stenestrand
  HIGH BLOOD PRESSURE AT ADMISSION TO THE INTENSIVE CARE UNIT FOR CHEST PAIN CONFERS A LOW LONG-TERM TOTAL MORTALITY in JOURNAL OF HYPERTENSION, vol 28, issue , pp E269-E269
  JOURNAL OF HYPERTENSION, 2010.


Karolina Szummer, Pia Lundman, Stefan Jacobson, Staffan Schon, Johan Lindback, Ulf Stenestrand, Lars Wallentin and Tomas Jernberg
  Statin Use After Myocardial linfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) in CIRCULATION, vol 120, issue 18, pp S501-S501
  CIRCULATION, 2009.


Axel Akerblom, Stefan K James, Michael Koutouzis, Bo Lagerqvist, Ulf Stenestrand, Bodil Svennblad and Jonas Oldgren
  Eptifibatide is Non-inferior to Abciximab in Acute Coronary Syndromes: Results From the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) in CIRCULATION, vol 120, issue 18, pp S1027-S1027
  CIRCULATION, 2009.


Johan Höglund, Ulf Stenestrand, Tim Tödt and Ingela Johansson
  Rapid ambulation after coronary angiography - a Swedish pilot study -
  ICCAD 2009, 8th International Congress on Coronary Artery Disease, 2009.


Thorarinn Gudnason, Hallveig Broddadottir, Frida Skuladottir, Hulda Halldorsdottir, Gestur Thorgeirsson, Karl Andersen and Ulf Stenestrand
  A comparison of quality indicators in the treatment of acute myocardial infarction in two Nordic countries
  in CARDIOLOGY, vol 113, 2009.


Lena M Bjorck, Ulf Stenestrand, Lars Wallentin and Annika Rosengren
  Medication in Relation to ST-Segment Elevation Myocardial Infarction: Findings from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
  CIRCULATION, ISSN 0009-7322: vol 119, issue 10, 2009.


Jonas Oldgren, Lisa Wernroth and Ulf Stenestrand
  Fibrinolytic Therapy and Bleeding Complications: Risk Predictors From SWEDEHEART
  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,ISSN 0735-1097: Volume 53, Issue 10, 2009.


 Web of Science® Times Cited: 1

S.K. James, Ulf Stenestrand, J Lindback, J Carlsson, F Schersten, T Nilsson, L Wallentin and B Lagerqvist
  Greatest benefit of drug stents vs bare metal stents in patients with diabetes, stable coronary disease and in small vessels
  ESC,2008, 2008.


L Björck, A Rosengren, L Wallentin and Ulf Stenestrand
  Medication in relation to ST-segment elevation myocardial infarction -findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)
  ESC,2008, 2008.


Ulf Stenestrand, S James, J Lindbäck, J Carlsson, F Schersten, T Nilsson, L Wallentin and B Lagerqvist
  The importance of large "real world" DES registries to assess complications and to validate inter-device comparisons.
  TCT 2008,2008, 2008.


A Samnegard, J Lindback, B Lagerqvist, C Hofman-Bang, Ulf Stenestrand and J.L. Persson
  Outcome after PCI in patients prescribed oral anticoagulants at discharge with or without clopidogrel.
  ESC,2008, 2008.


Ulf Stenestrand, S James, J Lindback, J Carlsson, F Schersten, T Nilsson, L Wallentin and B Lagerqvist
  Safety and efficacy of DES vs BMS in patients with diabetes mellitus, a four year follow up study from the SCAAR registry.
  ESC,2008, 2008.


B Lagerqvist, J Carlsson, O Frobert, J Lindback, Ulf Stenestrand and S James
  Differences in restenosis rate with different drug-eluting stents in diabetic and non-diabetic patients, a report from the Swedish angiography and angioplasty registry (SCAAR)
  ESC,2008, 2008.


Joakim Alfredsson, Ulf Stenestrand, J Lindback, L Wallentin and Eva Swahn
  Similar outcome in women and men with an invasive strategy
  ESC, 2008, 2008.


Joakim Alfredsson, Ulf Stenestrand, Sofia Lawesson and Eva Swahn
  Gender differences in level of care, management and outcome in non ST-elevation acute coronary syndromes.
  ESC,2008, 2008.


Ulf Stenestrand, S James, J Lindback, O Fröbert, J Carlsson, F Schersten, T Nilsson and B Lagerqvist
  Updates from important DES clinical trials: SCAAR registry (focus on diabetes)
  TCT 2008,2008, 2008.


Harry Hemingway, Ruoling Chen, Jacqueline Damant, Natalie Fitzpatrick, Aroon Hingorani, Bruce Keogh, Kate McAllister, Martin Henriksson, Keith Abrams, Magnus Janzon, Ulf Stenestrand, Juan-Carlos Kaski, Adam Timmis, Stephen Palmer and Mark Sculpher
  Cost-effectiveness of circulating biomarkers in managing stable coronary disease.
  SMDM,2008, 2008.


Helene Zachrisson, Anders Persson, Jan Engvall, Ulf Stenestrand and Magnus Janzon
  CT angiography - clinical experience from Linköping University Hospital
  X Svenska Kardiovaskulära Vårmötet,2008, 2008.


Karolina Szummer, Pia Lundman, Stefan Jacobson, Staffan Schon, Johan Lindback, Ulf Stenestrand, Lars Wallentin and Tomas Jemberg
  Early Invasive Therapy in Non-ST-elevation Myocardial Infarction Improves Survival Although Benefit Declines with Worsening Renal Function - Data from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
  CIRCULATION,ISSN 0009-7322: Volume 118 Issue 18, 2008.


Karolina Szummer, Pia Lundman, Stefan Jacobson, Staffan Schon, Johan Lindback, Ulf Stenestrand, Lars Wallentin and Tomas Jernberg
  Myocardial Infarction, Clinical Characteristics and Prognosis across Five Renal Function Stages - Data from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)
  CIRCULATION,ISSN 0009-7322: Volume 118 Issue 18, 2008.


Ulf Stenestrand
  The gap between evidence based medicine and clinical practice in ACS - the Swedish experience
  41st annual meeting of the European Society of Clinical Investiation,2007, 2007.


Sofia Lawesson, Ulf Stenestrand, L Wallentin and Eva Swahn
  Young women with ST-elevation myocardial infarction - coronary stenoses as often as men but three times higher early mortality
  ESC 2007,2007, 2007.


J Carlsson, Ulf Stenestrand, I Mueller and B Lagerqvist
  Coronary angiography and intervention in the very elderly: temporal trends, indications, and survival in 13,889 patients >=80 years of age
  ESC 2007,2007, 2007.


Ulf Stenestrand, S James, J Carlsson, J Lindbäck, T Nilsson, L Wallentin and B Lagerqvist
  Updates and insights from the SCAAR multicenter national DES and BMS registry
  TCT 2007,2007, 2007.


Ulf Stenestrand
  Large continuous real world registries are necessary for Inter-device comparisons
  TCT 2007,2007, 2007.


Ulf Stenestrand
  Primary PCI vs. Thrombolysis: The RIKS-HIA Experience (emphasis on the importance of time)
  TCT 2007,2007, 2007.


S James, J Carlsson, J Lindbäck, T Nilsson, Ulf Stenestrand and L Wallentin
  Outcome of drug eluting compared to bare metal stents in Sweden - a learning experience
  TCT 2007,2007, 2007.


Ulf Stenestrand, L Wallentin, K Gränsbo, O Melander and J Carlsson
  Is invasive strategy a feasible alternative for acute coronary syndromes in patients older than 80 years?
  AHA 2007,2007, 2007.


Ulf Stenestrand
  Platelet inhibition in acute coronary syndromes
  Masterclass,2007, 2007.


Ulf Stenestrand
  Primary PCI vs Thrombolysis: The Swedish Real World Experience.
  Myocardial infarction Challenge 4,2007, 2007.


Ulf Stenestrand
  The Swedish approach: assessment of quality of care with registries - the RIKS-HIA example.
  Workshop Berliner Herzinfarktregister,2007, 2007.


Ulf Stenestrand
  How to use large data registers
  Bleeding complications in the treatment of Acute Coronary Syndrome,2007, 2007.


Ulf Stenestrand
  Lysis vs PCI - is there still an indication for lysis? Data from the Swedish RIKS-HIA registry.
  Spring Meeting Heart Center,2007, 2007.


Ulf Stenestrand
  Primär PCI till alla i Sverige eller är det rimligt med regionala skillnader? (Akut hjärtinfarkt - behandlingsstrategi 2007)
  IX Svenska Kardiovaskulära vårmötet,2007, 2007.


Ulf Stenestrand
  DES vs BMS: vinster och risker i registerdata (Läkemedelsavgivande stentar (DES))
  IX Svenska Kardiovaskulära vårmötet,2007, 2007.


Ulf Stenestrand
  Vilket är viktigast vid akuta coronara syndrom - kolesterol eller CRP?
  IX Svenska Kardiovaskulära vårmötet,2007, 2007.


Ulf Stenestrand
  Angioplasty management in the high-risk patient, a challenge for 2007: learning experiences from the Swedish registry.
  Thromboses et Urgences Coronaires,2007, 2007.


Ulf Stenestrand
  Läkemedelsstent, är det värt det?
  Cardiovascular Highlights,2007, 2007.


Ulf Stenestrand
  Different reperfusion strategies in patients with STEMI
  GISE meeting,,2007, 2007.


J Oldgren, J Lindbäck, Ulf Stenestrand and L Wallentin
  Increased bleeding complications in fibrinolytic treatment during 2002 to 2004 (RIKS-HIA)
  American College of Cardiology 54th Annual Scientific Session,2006, 2006.


C Held, P Tornvall and Ulf Stenestrand
  Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery by-pass graft surgery.
  World Congress of Cardiology - ESC,2006, 2006.


Ulf Stenestrand
  Invasiv kardiologi hos de äldre patienterna.
  Svenskt Kardiovaskulärt Vårmöte,2006, 2006.


P Lindgren, Ulf Stenestrand, K Hambraeus, L Wallentin and Björn Jönsson
  PCI reduces utility loss after myocardial infarction in Sweden.
  World Congress of Cardiology - ESC,2006, 2006.


L Björck, A Rosengren, L Wallentin and Ulf Stenestrand
  Smoking and presentation with ST elevation in Swedish men and women with acute myocardial infarction.
  World Congress of Cardiology - ECS,2006, 2006.


Ulf Stenestrand, J Lindbäck and L Wallentin
  Primär PCI eller prehospital fibrinolys vid akut hjärtinfarkt?
  Kvalitetsregisterkonferensen,2006, 2006.


Ulf Stenestrand, J Lindbäck and L Wallentin
  Time perspective of Primary PCI versus prehospital thrombolysis in patients with STEMI
  Acute Cardiac Care - ESC,2006, 2006.


Ulf Stenestrand and L Wallentin
  Does low molecular weight heparin influence outcome in patients with non ST-segment elevation myocardial infarction with or without early revascularisation in a real life setting?
  Congress of the European Society of Cardiology,2005, 2005.


Ulf Stenestrand and L Wallentin
  Primary PCI versus thrombolysis in patients with STEMI - a prospective cohort study of short and long-term outcome in the nationwide Swedish CCU-registry (RIKS-HIA) (2)
  Congress of the European Society of Cardiology,2005, 2005.


Ulf Stenestrand
  Temporal Trends in Congestive Heart Failure Post Acute Myocardial infarction in 117201 Patients
  AHA Scientific Sessions,2005, 2005.


Ulf Stenestrand and L Wallentin
  Primary PCI versus prehospital thrombolysis in patients with STEMI - short and long-term outcome in the nationwide Swedish CCU-registry (RIKS-HIA)
  AHA Scientific Sessions,2005, 2005.


Ulf Stenestrand
  Förbättring av hjärtsjukvården med stöd av register - 10 år erfarenhet och effekter av RIKS-HIA
  Kvalitetsregisterdagarna,2005, 2005.


A Norhammar, J Lindback, L Ryden, Ulf Stenestrand and L Wallentin
  Improved mortality after myocardial infarction in patients with diabetes mellitus
  Congress of the European Society of Cardiology,2005, 2005.


A Norhammar, J Lindback, Ulf Stenestrand, L Wallentin and L Ryden
  Younger diabetic women are a high-risk group after myocadial infarction
  Congress of the European Society of Cardiology,2005, 2005.


E Björklund, Ulf Stenestrand, J Lindback and L Svensson
  Prehospital diagnosis and start of treatment reduces time delay and mortality in real life patients with STEMI
  Congress of the European Society of Cardiology,2005, 2005.


E Björklund, Ulf Stenestrand, J Lindback and L Svensson
  A prehospital diagnostic strategy reduces time to treatment and mortality in real life STEMI patients treated with primary percutaneous coronary intervention
  Congress of the European Society of Cardiology,2005, 2005.


Ulf Stenestrand
  NSTEMI ACS Registries: what do they tell us about high-risk presentation?
  PCI Risk Stratification for NSTEMI-ACS - A Biomarkers Masterclass,2005, 2005.


L Wallentin, K Spångberg and Ulf Stenestrand
  Improvement in outcome of acute myocardial infarction by implementation of new treatment methods in Sweden - 10 years experience with the Swedish national continuous registry of acute cardiac care.
  6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke,2005, 2005.


Ulf Stenestrand and L Wallentin
  Primary PCI versus thrombolysis in patients with STEMI - a prospective cohort study of short and long-term otucome in the nationwide Swedish CCU-registry (RIKS-HIA)
  Nordic Cardiovascular Meeting,2005, 2005.


Ulf Stenestrand and L Wallentin
  Does low molecular wight heparin influence outcome in patients with non ST-segment elevation myocardial infarction with or without early revascularization in a real-life setting?
  American College of Cardiology, 53rd annual scientific session,2005, 2005.


Joakim Alfredsson, Ulf Stenestrand, L Wallentin and Eva Swahn
  Sex-based differences in management and outcome in unstable coronary artery disease
  Second International Conference on Women, Heart disease and Stroke,2005, 2005.


Sofia Lawesson, Ulf Stenestrand, L Wallentin and Eva Swahn
  Differences in management and outcome of acute ST-elevation myocardial infarction
  Second International Conference on Women, Heart Disease and Stroke,2005, 2005.


 Web of Science® Times Cited: 1

Sofia Lawesson, Ulf Stenestrand, L Wallentin and Eva Swahn
  Delay-times and rate of acute reperfusion therapy in ST-elevation myocardial infarction differ between men and women
  Second International Conference on Women, Heart Disease and Stroke,2005, 2005.


Ulf Stenestrand and J-E Karlsson
  Riktlinjer och dagens verklighet i registren.
  Socialsytrelsen och Svenska Cardiologföreningens seminarium Nationella riktlinjer för hjärtsjukvård - Dagsläget, implementering och framtida utveckling,2004, 2004.


Ulf Stenestrand
  Databases and electronic medical records - The RIKS-HIA Swedish database
  European Society of Cardiology Working Group on Acute Cardiac Care,2004, 2004.


Ulf Stenestrand
  Acute coronary syndromes: guidelines vs. clinical practice in Europe - Swedish registry of myocardial infarction
  European Society of Cardiology Working Group on Acute Cardiac Care,2004, 2004.


Ulf Stenestrand
  Diabetes and its consequences in the CCU: results from the Swedish CCU registry
  European Society of Cardiology Working Group on Acute Cardiac Care,2004, 2004.


Ulf Stenestrand
  Biokemiska markörer i hjärtinfarktvården
  EQUALIS,2004, 2004.


Joakim Alfredsson, Eva Swahn, Ulf Stenestrand and L Wallentin
  ST-segment depression and elevated biochemical cardiac markers are highly predictive of worse outcome in both women and men.
  XXVI Congress of the European Soceity of Cardiology,2004, 2004.


Ulf Stenestrand, J Lindbäck and L Wallentin
  Underutilisation of oral anticoagulants for atrial fibrillation in survivors of acute myocardial infarction influences long-term mortality.
  XXVI Congress of the European Soceity of Cardiology,2004, 2004.


Ulf Stenestrand and L Wallentin
  Improvement of long-term outcome in acute myocardial infarction over time - experiences from RIKS-HIA
  XXVI Congress of the European Society of Cardiology,2004, 2004.


Ulf Stenestrand
  Statins in ACS and post PCI
  Nordic Meeting in Interventional Cardiology,2004, 2004.


Ulf Stenestrand, J Lindbäck and L Wallentin
  Patient characteristics adjusted quality of care study reveals that hospital therapy traditions influence survival in patients with acute myocardial infarction.
  5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke,2004, 2004.


Ulf Stenestrand, J Lindbäck and L Wallentin
  Underbehandling med antikoagulantia vid samtidigt förmaksflimmer hos hjärtinfarktpatienter
  Kardiovaskulärt vårmöte,2004, 2004.


Ulf Stenestrand and L Wallentin
  Förbättring av långtidsresultat vid hjärtinfarkt över tiden - resultat från RIKS-HIA
  Kardiovaskulärt vårmöte,2004, 2004.


Ulf Stenestrand and L Wallentin
  Underutilization of oral anticoagulants for atrial fibrillation in survivors of acute myocardial infarction influences long-term mortality
  American College of Cardiology 53rd Annular Scientific Session,2004, 2004.


Ulf Stenestrand and L Wallentin
  Improvement of long-term outcome in acute myocardial infarction overtime - experiences from RIKS-HIA
  Americak College of Cardiology 53rd Annual Scientific Session,2004, 2004.


Ulf Stenestrand
  Therapy and outcome in patients with myocardial infarction and diabetes mellitus - myths, trials, and reality.
  2nd Insulin Resistance Symposium,2004, 2004.


Joakim Alfredsson, Sofia Sederholm Lawesson, Ulf Stenestrand, Lars Wallentin and Eva Swahn
  Gender influence tretment and outcome of patients with unstable coronary artery disease.
  European Heart Journal,2003, 2003.


Sofia Lawesson, Joakim Alfredsson, Ulf Stenestrand, Lars Wallentin and Eva Swahn
  Sex differences in rate of thrombolysis in acute ST-evation myocardial infarction is caused by longer delay times in women.
  European Heart Journal,2003, 2003.


Joakim Alfredsson, Sofia Sederholm Lawesson, Ulf Stenestrand, Lars Wallentin and Eva Swahn
  Unstable coronary artery disease - a missed diagnosis.
  European Heart Journal,2003, 2003.


Sofia Lawesson, Joakim Alfredsson, Ulf Stenestrand, Lars Wallentin and Eva Swahn
  Management of acute ST-elevation myocardial infarction differs between the sexes which may impair the outcome for the female patient.
  European Heart Journal,2003, 2003.


E Bjorklund, M Dellborg, B Lindahl, K Pehrsson, Ulf Stenestrand, Eva Swahn, F Van de Werf and L Wallentin
  Outcome of myocardial infarction in the unselected population is vastly different from samples of eligible patients in large-scale clinical trials
  European Heart Journal, 2002.


David Westin, Ulf Stenestrand, L Wallentin and Eva Swahn
  Prognostic importance of rest electrocardiogram for a large population of coronary care unit-patients (CCU): a one year follow-up
  European Heart Journal, 2002.


Ulf Stenestrand and L Wallentin
  Early revascularization improves 1-year survival in 14-day survivors of acute myocardial infarction
  European Heart Journal, 2002.


Ulf Stenestrand and L Wallentin
  Early statin treatment improves long-term survival in patients discharged alive after acute myocardial infarction
  Journal of the American College of Cardiology, 2001.


Ulf Stenestrand and L Wallentin
  Thrombolysis is beneficial in elderly acute myocardial infarction patients
  Journal of the American College of Cardiology, 2001.


A Norhammar, K Malmberg, L Ryden, P Tornvall, Ulf Stenestrand and L Wallentin
  Under-utilisation of evidence-based treatment a partial explanation to the unfavourable prognosis in diabetic patients with acute myocardial infarction
  Circulation, 2001.


Ulf Stenestrand and L Wallentin
  Improvement of long term outcome in ST-elevation, acute myocardial infarction (AMI) - Experiences from the Swedish Registry of Cardiac Intensive Care.
  Circulation, 2000.


Ph.D. Theses

Sofia Sederholm Lawesson
  Management and Outcome in ST-Elevation Myocardial Infarction from a Gender Perspective
  2012.


  Fulltext PDF

Joakim Alfredsson
  Management and Outcome in Non ST-Elevation Acute Coronary Syndromes: Similarities and Differences Between Women nad Men
  2009.


  Fulltext PDF

Improving outcome in acute myocardial infarction
  2002.


Reports

Mikael Rahmqvist, Lars-Åke Levin and Ulf Stenestrand
  Utvärdering av Socialstyrelsens riktlinjer för prioritering i hjärtsjukvård 2001-2006
  Rapport / PrioriteringsCentrum, 3, 2008.


Ulf Stenestrand and L Wallentin
  RIKS-HIA 2007 - RIKS-HIAårsrapport för 2006 inklusive öppna jämförelser
  2007.


Mikael Rahmqvist, Lars-Åke Levin and Ulf Stenestrand
  Utvärdering av Socialstyrelsens riktlinjer för prioritering i hjärtsjukvård 2001-2004
  2006.


Ulf Stenestrand and Lars Wallentin
  RIKS-HIA årsrapport för 2005 inklusive öppna jämförelser.
  2006.


L Wallentin, Kalle Spångberg, Johan Lindbäck, Inger Hagerman, Ole Hansen, Claes Held, Jan-Erik Karlsson, Bertil Lindahl, Ewa Mattson, Thomas Mooe, Ulf Näslund, Monica Sterner, Lars Svennberg, Per Werner and Ulf Stenestrand
  Kalle Öppen redovisning av vårdinsatser och resultat vid behandling av akut hjärtinfarkt på olika sjukhus i Sverige år 2004. Nätbilaga till RIKS-HIA årsrapport 2005
  2005.


Ulf Stenestrand and L Wallentin
  RIKS-HIA årsrapport 2005 - RIKS-HIA 10 år 1995 - 2004
  2005.


Ulf Stenestrand and Lars Wallentin
  RIKS-HIA rapport 2002
  2002.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.